Related Experiment Video

Updated: Aug 11, 2026

Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease
07:22

Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease

Published on: November 8, 2017

Increased level of cerebrospinal fluid beta 2-microglobulin is related to neurologic impairment in multiple sclerosis

O W Bjerrum1, F W Bach, I Zeeberg

  • 1Department of Internal Medicine, Gentofte Hospital, Copenhagen, Denmark.

Acta Neurologica Scandinavica
|July 1, 1988
PubMed

Insights

Beta 2-microglobulin levels in cerebrospinal fluid (CSF) were measured in multiple sclerosis (MS) patients. Elevated CSF beta 2-microglobulin concentrations were observed in some MS patients, potentially indicating lesion formation.

Area of Science:

  • Neuroimmunology
  • Biomarker Discovery
  • Neurology

Background:

  • Multiple Sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system.
  • Identifying reliable biomarkers for MS activity and progression is crucial for patient management.
  • Beta 2-microglobulin (B2M) is a protein found on the surface of most nucleated cells, and its levels can indicate cellular turnover or inflammation.

Purpose of the Study:

  • To investigate the concentration of beta 2-microglobulin in the cerebrospinal fluid (CSF) of patients with multiple sclerosis.
  • To determine if elevated CSF beta 2-microglobulin levels correlate with disease severity or lesion formation in MS.

Main Methods:

  • Cerebrospinal fluid (CSF) samples were collected from 33 patients diagnosed with multiple sclerosis (MS).
  • Beta 2-microglobulin (B2M) concentrations were measured in the CSF of MS patients.
  • These levels were compared to a 95% confidence interval established in an age-matched control group of 32 individuals without neurological disease.
  • Neurological impairment was assessed using Kurtzke's expanded disability scale.

Main Results:

  • Six out of 33 MS patients (18%) exhibited moderately increased beta 2-microglobulin concentrations in their CSF.
  • This subgroup of MS patients with elevated CSF B2M also displayed severe neurological impairment as measured by Kurtzke's scale.
  • No significant correlation was made between B2M levels and age.

Conclusions:

  • Elevated cerebrospinal fluid beta 2-microglobulin may serve as a potential biomarker in multiple sclerosis.
  • Increased CSF B2M concentrations in MS patients could be indicative of active lesion formation or ongoing central nervous system inflammation.
  • Further research is warranted to validate B2M as a prognostic or diagnostic marker in MS.

More Related Videos

An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice06:40

An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice

Published on: March 19, 2018

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice08:23

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice

Published on: November 29, 2019

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

Overview
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Cerebral Edema l: Introduction01:19

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...